The Clearwater team advised the owners on the sale of Eduard Vogt AG to Galenica AG.
Eduard Vogt AG is a pharmaceutical company specialising in the development and production of various innovative products, including insect repellent branded products "Anti Brumm".
Galenica AG, a leading healthcare company, recognised Eduard Vogt's strong product portfolio and manufacturing capabilities, viewing the acquisition as a strategic opportunity to expand its presence in the generic pharmaceutical market.
The partnership aims to leverage market synergies and expertise to drive innovation.